Table 1.
Demographics, Insurance, and Diagnoses of Eligible Patients; Rates of Treatment Receipt by Demographic, Insurance, and Diagnostic Group; and Association of Age With Treatment Receipt, by Implementation Period
| Variablea | Preimplementation Period | Postimplementation Period | |||||||
|---|---|---|---|---|---|---|---|---|---|
| All (n = 1,761)b | Received NRT (n=768) | WTQL Referral (n=16) | Any Treatment (n=772) | All (n=2,214) | Pharmacist Addressed Tobacco Use (n=1,383) | Received NRT (n=1,115) | WTQL Referral (n=264) | Any Treatment (n=1,164) | |
| Sex | |||||||||
| Female | 792 (45.0) | 321 (40.5)c | 5 (0.6) | 324 (40.9)c | 1,004 (45.4) | 616 (61.4) | 498 (49.6) | 117 (11.7) | 523 (52.1) |
| Male | 969 (55.0) | 447 (46.1) | 11 (1.1) | 448 (46.2)c | 1,210 (54.7) | 767 (63.4) | 617 (51) | 147 (12.2) | 641 (53) |
| Race | |||||||||
| Black | 175 (9.9) | 64 (36.6) | 0 (0) | 64 (36.6) | 237 (10.7) | 138 (58.2) | 108 (45.6) | 30 (12.7) | 114 (48.1) |
| Other/unknown | 61 (3.5) | 25 (41) | 0 (0) | 25 (41) | 89 (4) | 55 (61.8) | 44 (49.4) | 6 (6.7) | 44 (49.4) |
| White | 1,525 (86.6) | 670 (43.9) | 16 (1.1) | 683 (44.8) | 1,888 (85.3) | 1,190 (63) | 963 (51) | 228 (12.1) | 1,006 (53.3) |
| Ethnicity | |||||||||
| Hispanic | 47 (2.7) | 12 (25.5)c | 1 (2.1) | 12 (25.5)c | 77 (3.5) | 48 (62.3) | 32 (41.6) | 7 (9.1) | 34 (44.2) |
| Other/unknown | 27 (1.5) | 15 (55.6) | 0 (0) | 15 (55.6) | 34 (1.5) | 25 (73.5) | 20 (58.8) | 3 (8.8) | 20 (58.8) |
| Non-Hispanic | 1,687 (95.8) | 741 (43.9) | 15 (0.9) | 745 (44.2) | 2,103 (95) | 1,310 (62.3) | 1,063 (50.5) | 254 (12.1) | 1,110 (52.8) |
| Insurance | |||||||||
| Commercial | 695 (39.5) | 286 (41.2) | 7 (1) | 287 (41.3) | 795 (35.9) | 491 (61.8) | 370 (46.5)c | 103 (13) | 392 (49.3)c |
| Medicaid | 493 (28) | 251 (50.9)c | 3 (0.6) | 253 (51.3)c | 675 (30.5) | 413 (61.2) | 376 (55.7)c | 75 (11.1) | 388 (57.5)c |
| Medicare | 546 (31) | 221 (40.5) | 6 (1.1) | 222 (40.7) | 719 (32.5) | 467 (65) | 355 (49.4) | 85 (11.8) | 370 (51.5) |
| Other/unknown | 27 (1.5) | 10 (37) | 0 (0) | 10 (37) | 25 (1.1) | 12 (48) | 14 (56) | 1 (4) | 14 (56) |
| Primary diagnosis | |||||||||
| Cancer | 39 (2.2) | 12 (30.8) | 0 (0) | 12 (30.8) | 66 (3) | 47 (71.2) | 34 (51.5) | 12 (18.2) | 35 (53) |
| CVMD | 265 (15.1) | 116 (43.8) | 4 (1.5) | 117 (44.2) | 333 (15) | 206 (61.9) | 180 (54.1) | 54 (16.2)c | 194 (58.3) |
| Pulmonary | 41 (2.3) | 22 (53.7) | 2 (4.9) | 22 (53.7) | 62 (2.8) | 44 (71) | 35 (56.5) | 7 (11.3) | 36 (58.1) |
| Other | 1,416 (80.4) | 618 (43.6) | 10 (0.7) | 621 (43.9) | 1,753 (79.2) | 1,086 (62) | 866 (49.4) | 191 (10.9)c | 899 (51.3) |
| Age, mean (SD), years | 51.2 (15.3) | 50.2 (14.7) | 59.1 (6.8)c | 50.2 (14.7) | 51.5 (15.1) | 52.4 (15) | 50.9 (14.7) | 52.8 (13)c | 50.9 (14.7)c |
| Mean difference (standard error), yearsd | 1.9 (0.7) | –7.9 (3.8) | 1.8 (0.7) | –0.3 (0.5) | –2.4 (0.7) | 1.2 (0.6) | –1.5 (1) | 1.2 (0.6) | |
| Total | 1,761 (100) | 768 (43.6) | 16 (0.9) | 772 (43.8) | 2,214 (100) | 1,383 (62.5) | 1,115 (50.4) | 264 (11.9) | 1,164 (52.6) |
Abbreviations: CVMD, cardiovascular or metabolic disease; NRT, nicotine replacement therapy; WTQL, Wisconsin Tobacco Quit Line.
aData are shown as No. (%) unless indicated otherwise.
bExcludes 4 pilot services.
cStatistically significant difference (P < 0.05). Comparison group is all other groups.
dMean difference between those who received treatment and those who did not: negative values indicate that those who received treatment were older than those who did not, while positive values indicate that those who received treatment were younger than those who did not, on average.